Christiaan M Roosendaal

3PUBLICATIONS
4CO-AUTHORS
Nanotoxicology, health and safetyGene and molecular therapyNanomedicine
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Mar 25, 2025
Low natalizumab trough concentrations are associated with reduced seroconversion of the John Cunningham virus in natalizumab-treated patients with multiple sclerosis.

Liza M Y Gelissen, Alyssa A Toorop, Pien M Schipper

|Nov 14, 2023
Prospective trial of natalizumab personalised extended interval dosing by therapeutic drug monitoring in relapsing-remitting multiple sclerosis (NEXT-MS).

Alyssa A Toorop, Zoë Ygj van Lierop, Liza My Gelissen

|Jan 13, 2023
Decrease of natalizumab drug levels after switching from intravenous to subcutaneous administration in patients with multiple sclerosis.

Alyssa A Toorop, Zoé L E van Kempen, Maurice Steenhuis

Pageof 1

Frequent Collaborators

3 joint publications

Alyssa A Toorop

3 joint publications

Zoé LE van Kempen

3 joint publications

Eva Mm Strijbis

1 joint publications

Liza M Y Gelissen